1. Home
  2. PZG vs ADVB Comparison

PZG vs ADVB Comparison

Compare PZG & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paramount Gold Nevada Corp.

PZG

Paramount Gold Nevada Corp.

HOLD

Current Price

$1.58

Market Cap

97.2M

ML Signal

HOLD

ADVB

Advanced Biomed Inc.

N/A

Current Price

$4.27

Market Cap

109.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PZG
ADVB
Founded
1992
2014
Country
United States
United States
Employees
N/A
31
Industry
Metal Mining
Medical Specialities
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.2M
109.2M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
PZG
ADVB
Price
$1.58
$4.27
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2M
174.9K
Earning Date
02-10-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$330,259.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.26
Revenue Growth
N/A
N/A
52 Week Low
$0.34
$0.19
52 Week High
$2.70
$5.82

Technical Indicators

Market Signals
Indicator
PZG
ADVB
Relative Strength Index (RSI) 30.22 57.88
Support Level $1.05 $0.36
Resistance Level $2.59 $5.75
Average True Range (ATR) 0.14 0.48
MACD -0.11 -0.20
Stochastic Oscillator 4.46 13.02

Price Performance

Historical Comparison
PZG
ADVB

About PZG Paramount Gold Nevada Corp.

Paramount Gold Nevada Corp is an exploration-stage mining company. Together with its subsidiaries, the company is engaged in the business of acquiring, exploring, and developing precious metal projects in the United States. Also, it explores for gold and silver. The company enhances the value of projects by implementing exploration and engineering programs that are likely to expand and upgrade known mineralized material to reserves. Its projects include sleeper gold, grassy mountain gold, frost project, other non-material, and others.

About ADVB Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Share on Social Networks: